Categories: News

Epitomee Medical to Present the Epitomee Breakthrough Oral Delivery Platform at PODD 2024 Conference

CAESAREA, Israel, Oct. 15, 2024 /PRNewswire/ — Epitomee Medical Ltd. (TASE: EPIT) announces today that the company leadership intends to present Epitomee’s Oral Delivery of Biologics Platform at the 14th Annual PODD Conference – Partnership Opportunities in Drug Delivery, taking place in Boston, MA, October 28-29, 2024.

Presentation Title: “Breakthrough Device for Oral Delivery of Biologics”
Date & Time: October 22, 2024, 2:30 PM2:45 PM
Presenter: Dr. Gil Cohen, PhD, VP R&D

Epitomee’s presentation will cover the following topics:

  • The Epitomee Platform enables oral delivery of significant amounts of large molecules, including proteins and peptides.
  • The platform dramatically boosts bioavailability, offering game-changing alternative to traditional injections.
  • Epitomee’s advanced, needle-free platform precisely transports drugs to the small intestine and across the GI wall, ensuring effective bioavailability.

The PODD Conference, in its 14th year, brings together over 800+ delegates from pharma, biotech, drug delivery, investors and academia. The event fosters collaboration across industries, to develop more effective therapies, improve the patient experience and extend the lifecycle of medicines. PODD features innovative technologies to enhance the delivery of various drug types, including proteins, peptides, oncology therapeutics, small molecules and others. This year’s annual keynote will be delivered by Dr. Robert Langer of MIT.

Join us at PODD 2024 to learn how Epitomee Medical is transforming biologics delivery.

About Epitomee Medical:
Epitomee Medical, co-founded by Shimon Eckhouse, PhD and led by CEO Dan Hashimshony, PhD, is a pioneering health solutions company, committed to advancing innovative therapies. With a focus on safety, efficacy, and improving quality of life, Epitomee leads advancements in weight management and biologic drug delivery. For more information, visit: epitomeemedical.com

Contact details: Safi Landskroner, VP of Business Development: safi@epitomeemedical.com

Photo – https://healthtechnologynet.com/wp-content/uploads/2024/10/PODD_2024.jpg
Logo – https://healthtechnologynet.com/wp-content/uploads/2024/10/Epitomee_Medical_Logo.jpg 

View original content to download multimedia:https://www.prnewswire.com/news-releases/epitomee-medical-to-present-the-epitomee-breakthrough-oral-delivery-platform-at-podd-2024-conference-302276347.html

SOURCE Epitomee Medical

Staff

Recent Posts

Enable Me Reminds Women of the Importance of Regular Breast Screenings on National Mammogram Day Tomorrow

To aid in the early detection of breast cancer, Enable Me is offering Tampa Bay…

19 mins ago

Avodah Appoints Jonathan Malek as Chief Technology Officer

WESTLAKE, Texas, Oct. 17, 2024 /PRNewswire/ -- Avodah, an innovative technology company committed to enhancing…

3 hours ago

CodexIT Acquires Professional Services Company

Continues to enhance its patient-centric technology support and service capabilities   COLUMBUS, Ohio, Oct. 17, 2024…

3 hours ago

National Kidney Foundation Innovation Fund Invests in Revalia Bio to Advance Innovative Kidney Disease Therapeutics

NEW YORK, Oct. 17, 2024 /PRNewswire/ -- The National Kidney Foundation (NKF) Innovation Fund is…

3 hours ago

ALICORN Expands Virtual Primary Care for the Employer Market Through Partnership with Curai Health

ALICORN members will have access to text-based care 24/7 in all 50 states WASHINGTON, Oct.…

3 hours ago